Understanding precisely which regions of the protein contribute to pro-tumorigenic and tumor-suppressive phenotypes is important not only for answering these questions about the role of PTHrP in cancer progression but also for the successful use of the protein as a biomarker. The gene discussed is PTHLH; the disease is cancer.